Omalizumab may facilitate drug desensitization in patients failing standard protocols

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pediatric allergy and immunology 2022-05, Vol.33 (5), p.e13783-n/a
Hauptverfasser:	Gemici Karaaslan, Hatice Betul, Karabag Yilmaz, Esra, Gulmez, Ruveyda, Canpolat, Nur, Kiykim, Ayca, Cokugras, Haluk Cezmi
Format:	Artikel
Sprache:	eng
Schlagworte:	Anaphylaxis Anti-Allergic Agents - therapeutic use children Desensitization (Psychology) Desensitization, Immunologic - methods drug allergy drug desensitization Drug Hypersensitivity - diagnosis Drug Hypersensitivity - therapy Humans hypersensitivity Immunoglobulin E Kidney diseases Monoclonal antibodies nephrotic syndrome omalizumab Omalizumab - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!